argenx SE (argenx SE) Change In Inventory : $0 Mil (TTM As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is argenx SE Change In Inventory?

argenx SE's change in inventory for the quarter that ended in Dec. 2023 was $0 Mil. It means argenx SE's inventory stayed the same from Sep. 2023 to Dec. 2023 .

argenx SE's change in inventory for the fiscal year that ended in Dec. 2023 was $-83 Mil. It means argenx SE's inventory increased by $83 Mil from Dec. 2022 to Dec. 2023 .

argenx SE's Total Inventories for the quarter that ended in Dec. 2023 was $311 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. argenx SE's Days Inventory for the quarter that ended in Dec. 2023 was 358.91.

Inventory Turnover measures how fast the company turns over its inventory within a year. argenx SE's Inventory Turnover for the quarter that ended in Dec. 2023 was 0.25.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. argenx SE's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 0.38.

argenx SE Change In Inventory Historical Data

The historical data trend for argenx SE's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

argenx SE Change In Inventory Chart

argenx SE Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Inventory

Get a 7-Day Free Trial

-23.85

-83.88

-119.28

-83.03

argenx SE Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Inventory	Get a 7-Day Free Trial															-	-	-	-	-

argenx SE Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

argenx SE (NAS:ARGX) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

argenx SE's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	155.275	/	39.477	*	365 / 4
	=	358.91

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

argenx SE's Inventory Turnover for the quarter that ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	39.477	/	155.275
	=	0.25

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

argenx SE's Inventory to Revenue for the quarter that ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	155.275	/	406.837
	=	0.38

argenx SE Change In Inventory Related Terms

Thank you for viewing the detailed overview of argenx SE's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

argenx SE (argenx SE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » argenx SE (NAS:ARGX) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

ARGX:Mexico ARGXb:UK 0QW0:UK 1AEA:Germany 1AE:Germany 1AE:Germany A1RG34:Brazil ARGX:Belgium ARGX:Austria

Address

Laarderhoogtweg 25, Amsterdam, NH, NLD, 1101EB

Website

https://www.argenx.com

Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was approved in the U.S. in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022.